Novartis expands Pluvicto manufacturing footprint with FDA blessing of Indianapolis radiotherapy facility aliu Fri, 01/05/2024 – 11:16 More: Novartis expands Pluvicto manufacturing footprint with FDA blessing of Indianapolis radiotherapy facility Source: fierce
read moreAfter Pfizer’s exit, UCB splits from industry trade group BIO zbecker Fri, 01/05/2024 – 10:55 More: After Pfizer's exit, UCB splits from industry trade group BIO Source: fierce
read moreIQVIA, DeepIntent in ‘incredibly difficult moment’ abandon merger amid FTC scrutiny badams Fri, 01/05/2024 – 10:55 More: IQVIA, DeepIntent in ‘incredibly difficult moment’ abandon merger amid FTC scrutiny Source: fierce
read moreStudy finds no link between Novo Nordisk’s GLP-1 drugs and suicidal ideation kdunleavy Fri, 01/05/2024 – 10:31 More: Study finds no link between Novo Nordisk’s GLP-1 drugs and suicidal ideation Source: fierce
read moreBeleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer’s Spiriva fkansteiner Fri, 01/05/2024 – 09:15 More: Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva Source: fierce
read moreVd1-gd T cells were effective in predicting positive responses to ICI therapy More: Immune cell helps predict skin cancer patients’ responses to immunotherapies Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals